Oncolytics Biotech

ONC-T

TSE:ONC

3.24
0.05 (1.57%)
Oncolytics Biotech Inc. is a Canadian company headquartered in Calgary, Alberta, that is developing an intravenously delivered immuno-oncolytic virus called REOLYSIN® for the treatment of solid tumors and hematological malignancies.
More at Wikipedia

Analysis and Opinions about ONC-T

Signal
Opinion
Expert
Chart
DON'T BUY
DON'T BUY
August 8, 2018

The technicals do not look good at all – with a decline lasting over the past two months. He would not touch this one at all. A 50 day moving average would be a buy signal if it can trade back above it.

Show full opinionHide full opinion

The technicals do not look good at all – with a decline lasting over the past two months. He would not touch this one at all. A 50 day moving average would be a buy signal if it can trade back above it.

COMMENT
COMMENT
February 19, 2007
Phase 2 cancer company with some pretty decent results. They are a long way away from where they want to be. Product has huge potential.
Show full opinionHide full opinion
Oncolytics Biotech (ONC-T)
February 19, 2007
Phase 2 cancer company with some pretty decent results. They are a long way away from where they want to be. Product has huge potential.
Peter Hodson
Price
$2.410
Owned
No
WEAK BUY
WEAK BUY
September 24, 2004
Not aware of any upcoming short term catalysts. Continuing with their trials. Never had bad results. Very volatile and still early stage.
Show full opinionHide full opinion
Oncolytics Biotech (ONC-T)
September 24, 2004
Not aware of any upcoming short term catalysts. Continuing with their trials. Never had bad results. Very volatile and still early stage.
Peter Hodson
Price
$7.250
Owned
No
WAIT
WAIT
July 8, 2004
Has a pretty high beta, so the stock goes up and down like a yo-yo. Likes with the company is doing. At some point, a major pharmaceutical company will get interested in their technology. Would like to see more trials and results.
Show full opinionHide full opinion
Has a pretty high beta, so the stock goes up and down like a yo-yo. Likes with the company is doing. At some point, a major pharmaceutical company will get interested in their technology. Would like to see more trials and results.
Peter Hodson
Price
$7.150
Owned
No
DON'T BUY
DON'T BUY
September 9, 2003
If they can find the right deals and get through the clinical trials, the upside would be phenomenal. Very volatile right now.
Show full opinionHide full opinion
Oncolytics Biotech (ONC-T)
September 9, 2003
If they can find the right deals and get through the clinical trials, the upside would be phenomenal. Very volatile right now.
Peter Hodson
Price
$3.490
Owned
Unknown
WEAK BUY
WEAK BUY
July 10, 2003
A wild stock. Created a virus that could reduce cancer dramatically. Long term potential could be good. Trials have only been small ones. Risky.
Show full opinionHide full opinion
A wild stock. Created a virus that could reduce cancer dramatically. Long term potential could be good. Trials have only been small ones. Risky.
Peter Hodson
Price
$3.250
Owned
Unknown
WEAK BUY
WEAK BUY
June 2, 2003
Biotechs have had good moves. Has a ways to go before their drug is on the market. Speculative in the short term.
Show full opinionHide full opinion
Biotechs have had good moves. Has a ways to go before their drug is on the market. Speculative in the short term.
John Sinkins, CFA
Price
$4.000
Owned
Unknown
WEAK BUY
WEAK BUY
May 6, 2003
Interesting technology. Trials are turning out well, but too small a sampling at this time. Speculative.
Show full opinionHide full opinion
Interesting technology. Trials are turning out well, but too small a sampling at this time. Speculative.
Peter Hodson
Price
$2.550
Owned
Unknown
Showing 1 to 8 of 8 entries
  • «
  • 1
  • »

Oncolytics Biotech(ONC-T) Rating

Ranking : 1 out of 5

Bullish - Buy Signals / Votes : 0

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 0

Total Signals / Votes : 0

Stockchase rating for Oncolytics Biotech is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

Oncolytics Biotech(ONC-T) Frequently Asked Questions

What is Oncolytics Biotech stock symbol?

Oncolytics Biotech is a Canadian stock, trading under the symbol ONC-T on the Toronto Stock Exchange (ONC-CT). It is usually referred to as TSX:ONC or ONC-T

Is Oncolytics Biotech a buy or a sell?

In the last year, there was no coverage of Oncolytics Biotech published on Stockchase.

Is Oncolytics Biotech a good investment or a top pick?

Oncolytics Biotech was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for Oncolytics Biotech.

Why is Oncolytics Biotech stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is Oncolytics Biotech worth watching?

0 stock analysts on Stockchase covered Oncolytics Biotech In the last year. It is a trending stock that is worth watching.

What is Oncolytics Biotech stock price?

On 2021-05-14, Oncolytics Biotech (ONC-T) stock closed at a price of $3.24.